|
Volumn 17, Issue 6, 2015, Pages 638-648
|
Reversal of P-glycoprotein-mediated multidrug resistance by the novel tetrandrine derivative W6
|
Author keywords
multidrug resistance; P glycoprotein; reversing agents; Stephania tetrandra; tetrandrine; W6
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
BETA ACTIN;
DOXORUBICIN;
MITOGEN ACTIVATED PROTEIN KINASE 1;
MITOGEN ACTIVATED PROTEIN KINASE 3;
MULTIDRUG RESISTANCE PROTEIN;
MULTIDRUG RESISTANCE PROTEIN 1;
PACLITAXEL;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN INHIBITOR;
PROTEIN P53;
TETRANDRINE;
UNCLASSIFIED DRUG;
VINCRISTINE;
W 6;
BENZYLISOQUINOLINE DERIVATIVE;
TETRANDRINE DERIVATIVE W6;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
CANCER RESISTANCE;
CONTROLLED STUDY;
DOWN REGULATION;
DRUG ACCUMULATION;
DRUG EFFICACY;
DRUG POTENTIATION;
ENZYME ACTIVITY;
ENZYME PHOSPHORYLATION;
FLOW CYTOMETRY;
HUMAN;
HUMAN CELL;
IC50;
KB CELL LINE;
MCF 7 CELL LINE;
MULTIDRUG RESISTANCE;
NONHUMAN;
PROTEIN EXPRESSION;
STEPHANIA TETRANDRA;
ANTAGONISTS AND INHIBITORS;
CHEMICAL STRUCTURE;
DRUG EFFECTS;
DRUG RESISTANCE;
STEPHANIA TETRANDRA;
BENZYLISOQUINOLINES;
DOXORUBICIN;
DRUG RESISTANCE, MULTIPLE;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
KB CELLS;
MOLECULAR STRUCTURE;
P-GLYCOPROTEINS;
|
EID: 84938598047
PISSN: 10286020
EISSN: 14772213
Source Type: Journal
DOI: 10.1080/10286020.2015.1047772 Document Type: Article |
Times cited : (17)
|
References (24)
|